Techlead Next Public Company Limited (SET: TL-R)
Health Care · Pharmaceuticals · TH
฿0.45
+7.14% today · -18.2% 1Y
Techlead Next Public Company Limited (SET: TL-R) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $78.53M.
Over the last twelve months the share price has lost 18.2%, trading between 0.25 and 0.62.
Tweenvest scores Techlead Next Public Company Limited across four factors: quality 53/100, value 54/100, growth 100/100. Its strongest factor is growth.
TL-R price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $78.53M
- Revenue (TTM)
- $14.23M
- P/E
- 12.63
- EPS
- 0.04
- Dividend yield
- —
- Beta (5Y)
- 0.33
- 52-week high
- ฿0.62
- 52-week low
- ฿0.25
- Avg volume (3M)
- —
- Shares outstanding
- 5.70B
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,233.66 | -1.06% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $273.14 | +0.04% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $156.45 | +3.84% |
| Roche Holding AGSWX: ROP | $371.62B | CHF373.80 | +0.92% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £124.76 | +3.02% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.57 | +2.15% |
Figures last refreshed Aug 18, 2026.